ÂÜÀòÂÒÂ×

Samir Ounzain is the Co-founder, Chief Executive Officer, and Board Director of HAYA Therapeutics. Prior to this role, Samir was a Postdoctoral Researcher and Project Leader at CHUV | Lausanne university hospital, a Postdoctoral Researcher at University College London, and a Postdoctoral Researcher at Imperial College London. Samir began their academic journey as a PHD student at the University of Leicester and completed their undergraduate studies at the University of Leeds.